- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Dietary inflammatory index.
Displaying page 1 of 1.
| EudraCT Number: 2019-000645-12 | Sponsor Protocol Number: GFT505-219-8 | Start Date*: 2019-09-03 | |||||||||||
| Sponsor Name:GENFIT SA | |||||||||||||
| Full Title: A Double-Blind, Placebo-Controlled, Cross-over Phase II Study to Evaluate the Effect of a 6-week Elafibranor (120mg) treatment administered once daily on hepatic lipid composition in subjects with ... | |||||||||||||
| Medical condition: Subjects with Nonalcoholic Fatty Liver (NAFL) | |||||||||||||
|
|||||||||||||
| Population Age: Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2013-004750-24 | Sponsor Protocol Number: 2013003 | Start Date*: 2014-03-17 | |||||||||||
| Sponsor Name:Rode Kruis Ziekenhuis | |||||||||||||
| Full Title: Omega-3 fatty acids in bariatric gastric bypass surgery: effects on liver volume, immune response and erythrocyte function | |||||||||||||
| Medical condition: Patients qualified for bariatric surgery | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2009-011291-29 | Sponsor Protocol Number: RACE 3 | Start Date*: 2011-08-16 | |||||||||||
| Sponsor Name:Interuniversity Cardiology Institute of the Netherlands (ICIN) | |||||||||||||
| Full Title: Routine versus Aggressive Upstream Rhythm Control for Prevention of Early Atrial Fibrillation in Heart Failure: RACE 3 | |||||||||||||
| Medical condition: atrial fibrillation | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) NL (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2009-016761-29 | Sponsor Protocol Number: HE2013 | Start Date*: 2010-05-14 | ||||||||||||||||
| Sponsor Name:University of Birmingham | ||||||||||||||||||
| Full Title: A 48-WEEK PHASE II, RANDOMISED, DOUBLE BLINDED PLACEBO CONTROLLED, PARALLEL-GROUP, MULTI-CENTRE TRIAL ON LIRAGLUTIDE’S SAFETY, EFFICACY AND ACTION ON LIVER HISTOLOGY AND METABOLISM IN OVERWEIGHT PA... | ||||||||||||||||||
| Medical condition: Non-alcoholic steatohepatits (NASH) | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2021-006766-21 | Sponsor Protocol Number: MINI-SPIOMET | Start Date*: 2022-09-02 | |||||||||||
| Sponsor Name:Hospital de Girona Dr. Josep Trueta | |||||||||||||
| Full Title: Towards a treatment for accelerated maturation in girls testing spiomet in a randomised placebo controlled, multicentre study. | |||||||||||||
| Medical condition: Girls with advanced puberty and accelerated bone maturation. Polycystic Ovary Syndrome (PCOS) | |||||||||||||
|
|||||||||||||
| Population Age: Children, Under 18 | Gender: Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.